B. Riley reiterated their buy rating on shares of Augmedix (OTCMKTS:AUGX – Get Rating) in a report released on Thursday morning, PriceTargets.com reports.
Augmedix Stock Performance
OTCMKTS:AUGX opened at $1.56 on Thursday. The company has a current ratio of 2.07, a quick ratio of 2.07 and a debt-to-equity ratio of 2.04. The firm has a 50-day moving average price of $1.29 and a two-hundred day moving average price of $1.52. Augmedix has a twelve month low of $1.01 and a twelve month high of $3.55. The company has a market capitalization of $58.38 million, a P/E ratio of -2.33 and a beta of -0.65.
Get Augmedix alerts:Hedge Funds Weigh In On Augmedix
Several hedge funds have recently added to or reduced their stakes in AUGX. Russell Investments Group Ltd. purchased a new position in Augmedix during the 2nd quarter valued at about $592,000. Samjo Capital LLC purchased a new stake in shares of Augmedix during the first quarter worth about $779,000. Millrace Asset Group Inc. grew its holdings in shares of Augmedix by 16.9% during the second quarter. Millrace Asset Group Inc. now owns 909,492 shares of the company's stock worth $1,637,000 after buying an additional 131,708 shares in the last quarter. Blair William & Co. IL grew its holdings in shares of Augmedix by 577.5% during the first quarter. Blair William & Co. IL now owns 124,825 shares of the company's stock worth $367,000 after buying an additional 106,400 shares in the last quarter. Finally, TownSquare Capital LLC grew its holdings in shares of Augmedix by 31.6% during the second quarter. TownSquare Capital LLC now owns 274,791 shares of the company's stock worth $495,000 after buying an additional 65,981 shares in the last quarter. 73.93% of the stock is currently owned by hedge funds and other institutional investors.
About Augmedix
(Get Rating)Augmedix, Inc provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes, care gap reminders, HCC reminders, and after-visit summaries; and post-visit documentation consisting of coding, orders, and referrals.
Recommended Stories
- Get a free copy of the StockNews.com research report on Augmedix (AUGX)
- MarketBeat: Week in Review 12/26 – 12/30
- The Dogs Of Tech: It's Time For A Bite Of These Stocks
- Does This Acquisition Make Microsoft a Bear Market Buy?
- Is Kintara Therapeutics A Hidden Gem?
- Should You Warm up to Generac Stock for the Winter?
Receive News & Ratings for Augmedix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Augmedix and related companies with MarketBeat.com's FREE daily email newsletter.